Home > Balance Sheet > TORRENT PHARMACEUTICALS

TORRENT PHARMACEUTICALS
Sundry Debtors

    Back to Balance Sheet
TORRENT PHARMACEUTICALS is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
AD     Remove this Ad

TORRENT PHARMACEUTICALS Last 5 Year Sundry Debtors History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Sundry Debtors ₹1,866 Cr₹1,844 Cr₹1,944 Cr₹1,632 Cr₹1,523 Cr

What is the latest Sundry Debtors ratio of TORRENT PHARMACEUTICALS ?

The latest Sundry Debtors ratio of TORRENT PHARMACEUTICALS is ₹1,866 Cr based on Mar2025 Consolidated results.
Year Sundry Debtors
Mar2025₹1,866 Cr
Mar2024₹1,844 Cr
Mar2023₹1,944 Cr
Mar2022₹1,632 Cr
Mar2021₹1,523 Cr

How is Sundry Debtors of TORRENT PHARMACEUTICALS Trending?

Years Sundry Debtors % Change
Mar2025 ₹1,866 Cr
1.20
Mar2024 ₹1,844 Cr
-5.12
Mar2023 ₹1,944 Cr
19.07
Mar2022 ₹1,632 Cr
7.16
Mar2021 ₹1,523 Cr -

Compare Sundry Debtors of peers of TORRENT PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
TORRENT PHARMACEUTICALS ₹140,683.0 Cr 3.7% -4.9% 26% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹397,018.0 Cr -2.3% -8.5% -3% Stock Analytics
DIVIS LABORATORIES ₹162,454.0 Cr 5.3% -3.4% 3.4% Stock Analytics
DR REDDYS LABORATORIES ₹102,830.0 Cr 1.2% -4.2% 5.3% Stock Analytics
CIPLA ₹99,325.0 Cr 2.4% -7.2% -18.1% Stock Analytics
MANKIND PHARMA ₹85,816.7 Cr 3% -3.9% -15.4% Stock Analytics


TORRENT PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
TORRENT PHARMACEUTICALS

3.7%

-4.9%

26%

SENSEX

5.8%

-1.7%

1.2%


You may also like the below Video Courses